Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07136857) titled 'Eptacog Beta in Glanzmann's (HeT_LFB-Strength-Study_FID531)' on Aug. 15.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Emory University
Condition:
Glanzmann Thrombasthenia
Intervention:
Drug: EPTACOG BETA
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: August 2025
Target Sample Size: 6
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07136857
Published by HT Digital Content Services with permissi...